Drugs / sIPV
last change Apr 2023 re-read 3 minutes ago

sIPV

Vaccine

Developed for
poliomyelitis
Investigated by
Beijing Minhai Biotechnology Co., Ltd

Trials 1

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT07297186 Aug 2017 → Apr 2023 poliomyelitis Beijing Minhai Biotechnology Co., Ltd Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as sIPV ClinicalTrials.gov intervention name — accepted as the source's own label NCT07297186 ↗
Modality Vaccine “Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell)” NCT07297186 ↗